Physician profile
Eva Jo Bailey
NPI 1669476990
$5,368.56
in general payments reported to CMS, 2019-2025
24 companies · $708 in 2025
The $708 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,505 · 2020: $421 · 2021: $804 · 2022: $1,167 · 2023: $301 · 2024: $461 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,110.67 | 2019-2024 | Senza |
| Medtronic, INC. | $1,077.36 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Medtronic USA, INC. | $754.07 | 2019-2020 | |
| Amgen INC. | $378.30 | 2019-2022 | |
| Boston Scientific Corporation | $353.47 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $330.48 | 2020-2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $190.66 | 2025 | Senza |
| Vertiflex, INC. | $163.57 | 2019 | |
| Tersera Therapeutics LLC | $157.08 | 2025 | Prialt |
| Vertex Pharmaceuticals Incorporated | $150.62 | 2024-2025 | |
| Painteq LLC | $147.95 | 2022 | |
| Pfizer INC. | $112.16 | 2020-2021 | |
| Abbott Laboratories | $107.92 | 2019-2025 | Lamitrode Tripole, Eterna, Proclaim |
| Lundbeck LLC | $80.74 | 2023-2025 | Vyepti |
| Forte Bio-Pharma LLC | $47.25 | 2023 | Prolate, Nalocet |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $35.37 | 2022 | |
| Spinal Simplicity, LLC | $32.29 | 2021-2022 | |
| Saluda Medical Americas, INC. | $31.46 | 2025 | Evoke |
| Teva Pharmaceuticals USA, INC. | $25.17 | 2019 | |
| Fidia Pharma USA INC. | $18.85 | 2022 | |
| Si-Bone, INC. | $17.79 | 2025 | |
| Biogen, INC. | $15.73 | 2021 | |
| Vertical Pharmaceuticals, LLC | $15.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.